Yearly Archives: 2016

NeuroHealing Invited to Present at ‘Strategic Partnerships in Drug Repurposing’ Conference

Newton, Massachusetts – October 2016. NeuroHealing Pharmaceuticals, a private, clinical stage company developing innovative drug treatments for specialty indications based on repositioning neurologically active compounds announces the presentation of a case study entitled “A Comparison of Different Development Paths, Challenges and the Profiles of Three Repositioned Drugs” at the Strategic Partnerships in Drug Repurposing conference in…

U.S. Patent Office Issues Patents in NeuroHealing’s NH004 Program

Newton, Massachusetts – September 2016. NeuroHealing Pharmaceuticals, a private, clinical stage company developing innovative drug treatments for specialty indications based on repositioning neurologically active compounds, announces that the United States Patent and Trademark Office (USPTO) has issued to NeuroHealing two patents entitled ““Methods and Compositions for Decreasing Saliva Production.” The first patent (US 9,198,897), with a…

Publication of Clinical Study with Modafinil Supports NH02D Mechanism

May 2016. A research group led by Dr Ege Serefoglu has published the results of a clinical study showing that modafinil (racemate) increases the ejaculatory time and improves the patient reported outcomes for patients with premature ejaculation (Tuken et al, “On-Demand Modafinil Improves Ejaculation Time and Patient Reported Outcomes in Men with Lifelong Premature Ejaculation”,…